Substance use to enhance academic performance among Australian university students

Performance Enhancement and Health

Volumn 2, Issue 3, 2013, Pages 110-118

  Mazanov, Jason ^a   Dunn, Matthew ^b   Connor, James ^a   Fielding, Mai Lee ^a  

^a Australian Defence Force Academy   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

Author keywords

Australia; Cognitive enhancement; Cognitive enhancing drugs; Drug policy; Education policy

Indexed keywords

EID: 84887817941     PISSN: 22112669     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peh.2013.08.017     Document Type: Article

References (52)

1. Australian Government Student 2011 full year: Selected higher education statistics publication 2013, Australian Government, Canberra, Australia, Available at: Accessed 23.04.13. http://www.innovation.gov.au/HigherEducation/HigherEducationStatistics/StatisticsPublications/Pages/default.aspx.
2. Australian Institute of Health and Welfare National drug strategy household survey: First results 2011, Australian Government, Canberra, Australia.
3. Babcock Q., Byrne T. Student perceptions of methylphenidate abuse at a public liberal arts college. Journal of American College Health 2000, 49:143-145.
4. Barnes C.M., Wagner D.T., Ghumann S. Borrowing from sleep to pay work and family: Expanding time-based conflict to the broader nonwork domain. Personnel Psychology 2012, 65(4):789-819.
5. Cakic V. Smart drugs for cognitive enhancement: Ethical and pragmatic considerations in the era of cosmetic neurology. Journal of Medical Ethics 2009, 35:611-615.
6. Castaldi S., Gelatti U., Orizio G., Hartung U., Moreno-Londono A.M., Nobile M., et al. Use of cognitive enhancement medication among Northern Italian university students. Journal of Addiction Medicine 2012, 6:112-117.
7. Cross P., St.John F.A.V., Khan S., Petróczi A. Innovative techniques for estimating illegal activities in a human-wildlife-management conflict. PLoS ONE 2013, 8(1):e53681. 10.1371/journal.pone.0053681.
8. Curcio G., Ferrara M., de Genero L. Sleep loss, learning capacity and academic performance. Sleep Medicine Reviews 2006, 10(5):323-337.
9. DeSantis A.D., Webb E.M., Noar S.M. Illicit use of prescription ADHD medications on a college campus: A multimethodological approach. Journal of American College Health 2008, 57(3):315-323.
10. Dietz P., Striegel H., Franke A.G., Lieb K., Simon P., Ulrich R. Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students. Pharmacotherapy 2013, 33(1):44-50.
11. Ebejer J.L., Medland S.E., van der Werf J., Gondro C., Henders A.K., Lynskey M., et al. Attention deficit hyperactivity disorder in Australian adults: Prevalence, persistence, conduct problems and disadvantage. PLoS ONE 2012, 7(10):e47404. 10.1371/journal.pone.0047404.
12. Elsabagh S., Hartley D.E., Ali O., Williamson E.M., File S.E. Differential cognitive effects of Ginkgo biloba after acute and chronic treatment in healthy young volunteers. Psychopharmacology 2005, 179(2):437-446.
13. Forlini C., Racine E. Disagreements with implications: Diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement. BMC Medical Ethics 2009, 10:9. 10.1186/1472-6939-10-9.
14. Franke A.G., Bonertz C., Christmann M., Huss M., Fellgiebel A., Hildt E., et al. Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry 2011, 44:60-66.
15. Galesic M., Bosnjak M. Effects of questionnaire length on participation and indicator of response quality in a web survey. Public Opinion Quarterly 2009, 73:349-360.
16. Graham J., Nosek B.A., Haidt J., Iyer R., Spassena K., Ditto P.H. Mapping the moral domain. Journal of Personality and Social Psychology 2011, 101(2):366-385.
17. Greely H., Sahakian B., Harris J., Kessler R.C., Gazzaniga M., Campbell P., et al. Towards responsible use of cognition enhancing drugs by the healthy. Nature 2008, 456:702-705.
18. Gucciardi D.F., Jalleh G., Donovan R.J. An examination of the sport drug control model with elite Australian athletes. Journal of Science and Medicine in Sport 2011, 14:469-476.
19. Hall K.M., Irwin M.M., Bowman K.A., Frankenberger W., Jewett D.C. Illicit use of prescribed stimulant medication among college students. Journal of American College Health 2005, 53(4):167-174.
20. Housden C.R., Morein-Zamir S., Sahakian B.J. Cognitive enhancing drugs: Neuroscience and society. Enhancing human capacities 2011, 113-126. Wiley-Blackwell, Chichester, UK. J. Savulescu, R. ter Meulen, G. Kahane (Eds.).
21. Judson R., Langdon S.W. Illicit use of prescription stimulants among college students: Prescription status, theory of planned behaviour, knowledge and self-diagnostic tendencies. Psychology, Health & Medicine 2009, 14(1):97-104.
22. Kalmijn S., Feskens E.J., Launer L.J., Kromhout D. Polyunsaturated fatty acids, antioxidants and cognitive function in very old men. American Journal of Epidemiology 1997, 145:33-41.
23. Kennedy D., Jackson P., Elliott J., Scholey A., Robertson B., Greer J., et al. Cognitive and mood effects of 8 weeks' supplementation with 400mg or 1000mg of the omega-3 essential fatty acid docosahexaenoic acid (DHA) in healthy children aged 10-12 years. Nutritional Neuroscience 2009, 12(2):48-56.
24. Kimergård A. Policy recommendations to deal with academic doping in Denmark-a successful transfer of a doping control framework?. INHDR 2011, Available at: Accessed January 2011. http://www.doping.au.dk/.
25. Kirby K., Moran A., Guerin S. A qualitative analysis of the experience of elite athletes who have admitted to doping for performance enhancement. International Journal of Sport Policy and Politics 2011, 3(2):205-224.
26. Lanni C., Lenzken S.C., Pascale A., del Vecchio I., Racchi M., Pistoia F., et al. Cognitive enhancers between treating and doping the mind. Pharmacological Research 2008, 57:196-213.
27. Lee K.I., Koval J.J. Determination of the best significance level in forward stepwise logistic regression. Communication in Statistics-Simulation and Computation 1997, 26(2):559-575.
28. Low K.G., Gendaszek A.E. Illicit use of psychostimulants among college students: A preliminary study. Psychology, Health and Medicine 2002, 7(3):283-287.
29. Lucke J.C., Hall W. Is the non-medical use of prescription stimulants a problem in Australia?. Medical Journal of Australia 2012, 197(3):145.
30. Mazanov J., Byrne D.G. A comparison of predictors of the adolescent intention to smoke with adolescent current smoking using discriminant function analysis. British Journal of Health Psychology 2002, 7(2):185-201.
31. McCabe S.E., Knight J.R., Teter C.J., Wechsler H. Non-medical use of prescription stimulants among US college students: Prevalence and correlates from a national survey. Addiction 2005, 99:96-106.
32. McCabe S.E., Teter C.J. Drug use related problems among non-medical users of prescription stimulants: A web-based survey of college students from a Midwestern university. Drug and Alcohol Dependence 2007, 91(1):69-76.
33. McInnis C., Hartley R. Managing study and work 2002, Commonwealth of Australia, Canberra.
34. Partridge B., Lucke J.C., Hall W.D. A comparison of attitudes towards cognitive enhancement and legalized doping in sport in a community sample of Australian adults. AJOB Primary Research 2012, 3:81-86.
35. Partridge B.J., Bell S.K., Lucke J.C., Hall W.D. Australian university students' attitudes towards the use of prescription stimulants as cognitive enhancers: Perceived patterns of use, efficacy and safety. Drug and Alcohol Review 2013, 32:295-302.
36. Partridge B.J., Bell S.K., Lucke J.C., Yeates S., Hall W.D. Smart drugs as common as coffee: Media hype about neuroenhancement. PLoS ONE 2011, 6(11):e28416. 10.1371/journal.pone.0028416.
37. Petróczi A., Mazanov J., Nepusz T., Backhouse S.H., Naughton D.P. Comfort in big numbers: Does over-estimation of doping prevalence in others indicate self-involvement?. Journal of Occupational Medicine and Toxicology 2008, 3:19. 10.1186/1745-6673-3-19.
38. Rabiner D.L., Anastopoulos A.D., Costello E.J., Hoyle R.H., McCabe S.E., Swartzwelder H.S. Motives and perceived consequences of non-medical ADHD use by college students: Are students treating themselves for attention problems?. Journal of Attention Disorders 2009, 13(3):259-270.
39. Reissig C.J., Strain E.C., Griffiths R.R. Caffeinated energy drinks - A growing problem. Drugs and Alcohol Dependence 2009, 99:1-10.
40. Repantis D., Schlattman P., Laisney O., Heuser I. Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systemic review. Pharmacological Research 2010, 62:187-206.
41. Sandberg A. Cognition enhancement: Upgrading the brain. Enhancing human capacities 2011, 71-91. Wiley-Blackwell, Chichester, UK. J. Savulescu, R. ter Meulen, G. Kahane (Eds.).
42. Sandberg A., Savulescu J. The social and economic impacts of cognitive enhancement. Enhancing human capacities 2011, 92-112. Wiley-Blackwell, Chichester, UK. J. Savulescu, R. ter Meulen, G. Kahane (Eds.).
43. Schermer M. On the argument that enhancement is cheating. Journal of Medical Ethics 2008, 34:85-88.
44. Schermer M., Bolt I., de Jongh R., Olivier B. The future of psychopharmacological enhancements: Expectations and policies. Neuroethics 2009, 2:75-87.
45. Smith M.E., Farah M.J. Are prescription stimulants smart pills? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychological Bulletin 2011, 137:717-741.
46. Snitz S.E., O'Meara E.S., Carlson M.C., Arnold A.M., Ives D.G., Rapp S.R., et al. Ginkgo biloba for preventing cognitive decline in older adults. Journal of American Medical Association 2009, 302(24):2663-2670.
47. Spector P.E. Development of the work locus of control scale. Journal of Occupational Psychology 1988, 61:335-340.
48. Spector P.E. International norms for the Work Locus of Control Scale 2006, Available at: Accessed 27.09.12. http://shell.cas.usf.edu/~pspector/scales/wlcsnorm.html.
49. Teter C.J., Falone A.E., Cranford J.A., Boyd C.J., McCabe S.E. Non-medical use of prescription stimulants and depressed mood among college students: Frequency and routes of administration. Journal of Substance Abuse Treatment 2010, 38:292-298.
50. Teter C.J., McCabe S.E., LaGrange K., Cranford J.A., Boyd C.J. Illicit drug use of specific prescription stimulants among college students: Prevalence, motives and routes of administration. Pharmacotherapy 2006, 26(10):1501-1510.
51. White B.P., Becker-Blease K.A., Grace-Bishop K. Stimulant medication use, misuse and abuse in an undergraduate and graduate student sample. Journal of American College Health 2006, 54(5):261-268.
52. Wilens T.E., Adler L.A., Adams J., Sgambati S., Rotrosen J., Sawtell R., et al. Misuse and diversion of stimulants prescribed for ADHD: A systematic review of the literature. Journal of the American Academy of Child and Adolescent Psychiatry 2007, 47:21-31.